USANA Health Sciences, Inc. provided earnings guidance for the year 2023. For the year, the company is issuing its initial consolidated net sales of $850 million - $950 million. Diluted EPS of $2.35 - $3.30.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.75 USD | +1.18% | +3.61% | -16.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.51% | 861M | |
+5.54% | 7.59B | |
-2.62% | 7.36B | |
+0.22% | 5.93B | |
-8.57% | 3.66B | |
-14.55% | 3.38B | |
-15.31% | 1.16B | |
+12.72% | 979M | |
-39.38% | 922M | |
-16.86% | 800M |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- USANA Health Sciences, Inc. Provides Earnings Guidance for the Fiscal Year 2023